Common Stock, Shares Authorized of NKGen Biotech, Inc. from Q4 2020 to Q4 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
NKGen Biotech, Inc. quarterly Common Stock, Shares Authorized history and change rate from Q4 2020 to Q4 2024.
  • NKGen Biotech, Inc. Common Stock, Shares Authorized for the quarter ending 31 Dec 2024 was 500,000,000, unchanged year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Change (%)

NKGen Biotech, Inc. Quarterly Common Stock, Shares Authorized (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 500,000,000 0 0% 31 Dec 2024 10-K 08 Oct 2025 2024 FY
Q3 2024 500,000,000 0 0% 30 Sep 2024 10-Q 04 Mar 2025 2024 Q3
Q2 2024 500,000,000 +100,000,000 +25% 30 Jun 2024 10-Q 12 Sep 2024 2024 Q2
Q1 2024 500,000,000 +100,000,000 +25% 31 Mar 2024 10-Q 20 May 2024 2024 Q1
Q4 2023 500,000,000 0 0% 31 Dec 2023 10-K 08 Oct 2025 2024 FY
Q3 2023 500,000,000 +100,000,000 +25% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 400,000,000 0 0% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 400,000,000 0 0% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 500,000,000 +100,000,000 +25% 31 Dec 2022 10-K 16 Apr 2024 2023 FY
Q3 2022 400,000,000 0 0% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 400,000,000 0 0% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 400,000,000 0 0% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 400,000,000 0 0% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 400,000,000 30 Sep 2021 10-Q/A 31 Jan 2022 2021 Q3
Q2 2021 400,000,000 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 400,000,000 31 Mar 2021 10-K 31 Mar 2022 2021 FY
Q4 2020 400,000,000 31 Jan 2021 10-K 31 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.